Form 4: Kewaunee Scientific Corp Executive Sells Shares
SEC Form 4 Filing
A Kewaunee Scientific Corp executive, Douglas J. Batdorff, sold 3,470 shares of common stock at $65.5 per share on December 30, 2024.
Summary
- Douglas J. Batdorff, VP of Manufacturing Operations at Kewaunee Scientific Corp, sold 3,470 shares of common stock on December 30, 2024.
- The sale price was $65.5 per share.
- Following the transaction, Mr. Batdorff directly owns 5,000 shares of Kewaunee Scientific Corp stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale by an executive. It doesn't inherently suggest positive or negative sentiment.
Industry Context
This is a routine filing related to insider trading activity and is common for publicly traded companies.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, as required by the Securities and Exchange Commission (SEC).
- These filings are used to disclose changes in beneficial ownership by company insiders, such as officers and directors.
- The sale of shares by an executive is a common occurrence and does not necessarily indicate a negative outlook for the company.
Stakeholder Impact
- The sale of shares by an executive may be of interest to shareholders, but it is a common occurrence and does not necessarily indicate a negative outlook for the company.
Key Dates
| Date | Description |
|---|---|
| 12/30/2024 | Date of the stock sale transaction. |
| 01/02/2025 | Date the Form 4 was signed. |
Keywords
Kewaunee Scientific Corp, stock sale, insider trading, executive, common stock, KEQU, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.